Abstract 2212: An antibody drug conjugate targeting activated matriptase, exhibits synergistic cytotoxicity with a PARP inhibitor, olaparib in triple negative breast cancer
Authors: Gulam M. Rather, Zoltan Szekely, Joseph R. Bertino
Published: 2020-09-04
DOI:
10.1158/1538-7445.am2020-2212
Source:
Full article
Abstract
Abstract